The BioProcess International Conference is where challenges are explored, solutions are uncovered, and opportunities are developed, making it the largest and most highly respected event solely dedicated to biopharmaceutical manufacturing. Save time and reduce cost of goods with tips on streamlining processes and implementing novel technologies. Find new collaborators and partners with superior networking opportunities at the industry’s largest event devoted solely to biopharmaceutical production. Consult with >150 providers of novel and practical services and products in the exhibit hall. Present a poster of your own early results and receive feedback from your peers. Benchmark your company’s projects against industry leaders by hearing >180 case studies and cutting-edge presentations. Participate in strategic discussion forums to hear behind-the-scenes perspectives on the latest industry challenges. Get exclusive preevent access to attendees online at LinkedIn; start discussions with fellow attendees well before the conference. Develop valuable partnerships through rapid-fire “speed networking.”
Keynote Speakers
John G. Aunins (Merck Research Laboratories)
Jeffrey C. Baker (Office of Biotechnology Products (OBP) Center for Drug Evaluation and Research, U.S. FDA)
Michael Betenbaugh (Johns Hopkins University)
Timothy S. Charlebois (Pfizer)
Esa Heinonen (EMA Working Group on Biosimilars, Head of Section 2, Marketing Authorizations, Finnish Medicines Agency, Finland)
Steven Kozlowski (Office of Biotechnology Products, CDER, US FDA)
Robin A. Robinson (US Department of Health and Human Services)
Morris Rosenberg (Seattle Genetics)
Jay S. Stout (Merck & Co., Inc.)
New, Unpublished Data
Enhancing Manufacturing and Development Efficiency and Flexibility
Product Lifecycle Management
Cell Culture and Upstream Processing
Recovery and Purification
Vaccine Development and Production
Novel Approaches and Applications for Viral Clearance
Analytical Technologies for Biopharmaceutical Development
Developing your Competitive Edge in Biologics Drug Development
Biosimilars and Biobetters
Managing Global Manufacturing Facilities and Partners
Development and Production of Antibody Drug Conjugates
Formulation Strategies for Protein Therapeutics
Incorporating Single Use in Process Development and Scale-Up
Using Design of Experiments Effectively for Process Characterization
Understanding and Designing an Optimal Lyophilization Process
Attendees Say …
“An excellent forum for sharing lessons learned.” —Victor Awafo, deputy director of manufacturing technology at Sanofi Pasteur
“Always a great opportunity to get a very comprehensive overview on new trends in biologics process development, manufacturing aspects, and new trends in the biologics business.” —Wolfgang Noe, former vice president of bioprocess development at Biogen Idec
“A convergence of ideas from myriad perspectives. The pool helps you validate and/or reevaluate your own strategy. The overall result: a more knowledgeable biopharmaceutical industry.” —Nimish Gupta, process development engineer at Regeneron Pharmaceuticals Inc.
“A great opportunity to gain exposure to some of the most important topics in the industry through poster and speaker presentations, which allow attendees to interact and learn from their counterparts.” —Tom O’Brien, associate scientist at BD Advanced Bioprocessing
“Great opportunity for industrial networking.” —Joerg Von Hagen, R&D manager at Merck
“Great place to meet the technical experts in the industry. I enjoyed exchanging research ideas with global companies and sparking new collaboration.” —Kelvin Lau, senior process engineer at Abbott
Register Early
IBC has designed three- and four-day conferences package options to fit all your needs. Find complete details online, or call 1-800-309-4078. When registering, please mention this priority code: BPIFEOCT.
Exhibit Hall and Keynote Passes are now available. Find complete details online at www.IBCLifeSciences.com/ BPIPass. Mention code BPIFEOCT, and your exhibit hall and keynote pass fee will be waived when you register by October 26, 2011. All such passes are subject to IBC approval.